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Abstract
Background: Although mortality following pancreaticoduodenectomy is decreasing, postoperative mor-
bidity remains high. It was hypothesized that culture-directed treatment of bacteriobilia would decrease
the incidence of infectious complications following pancreaticoduodenectomy.
Methods: In a retrospective study of 197 pancreaticoduodenectomy patients, those in the control group
(n = 128, 2005–2009) were given perioperative prophylactic antibiotics, whereas those in the treatment
group (n = 69, 2009–2011) were continued on antibiotics until intraoperative bile culture results became
available. Patients with bacteriobilia received 10 days of antibiotic treatment, which was otherwise
discontinued in patients without bacteriobilia. Various complication rates were compared using Fisher's
exact test for categorical variables, Wilcoxon rank sum test for ordinal variables, and a two-sample t-test
for continuous variables.
Results: Demographics, comorbidities, baseline clinical characteristics, and intraoperative and postop-
erative variables were similar between the two groups. There were higher incidences of elevated
creatinine (19% versus 4%; P = 0.004) and preoperative hyperglycaemia (18% versus 7%; P = 0.053) in
the control group. Fewer patients in the control group underwent preoperative biliary stenting (48%
versus 67%; P = 0.017) and intraperitoneal drains were placed at the time of resection more frequently in
the control group (85% versus 38%; P < 0.001). Bacteriobilia was found in 59% of patients. Treatment of
bacteriobilia was associated with a decrease in the rate of postoperative wound infections (12% in the
control group versus 3% in the treatment group; P = 0.036) and overall complication severity score (1 in
the control group versus 0 in the treatment group; P = 0.027).
Conclusions: Prolonged antibiotic therapy for bacteriobilia may decrease postoperative wound
infection rates after pancreaticoduodenectomy. A randomized prospective trial is warranted to provide
evidence to further support this practice.
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Introduction
In recent decades, modifications in operative technique and
perioperative management have decreased the mortality associ-
ated with pancreaticoduodenectomy from the 30% reported in
the 1940s to current rates of <3% at most high-volume centres.
Despite improvements in mortality, rates of postoperative com-
plications remain high.1 The most common complications follow-
ing pancreaticoduodenectomy include pancreatic fistula, delayed
gastric emptying, wound infection and intra-abdominal abscess.
Infectious complications result in longer hospital stays, higher
costs, additional invasive procedures and increased patient
morbidity. The implementation of measures to reduce infectious
complications after pancreaticoduodenectomy would signifi-
cantly advance the field of pancreatic surgery.
This manuscript was presented at the annual AHPBA meeting, Miami, 7–11
March 2012.
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Preoperative biliary stenting has been associated with an
increased risk for various postoperative complications, including
wound infections and intra-abdominal abscesses.2–4 It has been
hypothesized that bacteriobilia associated with biliary stenting is
responsible for the increase in infectious complications.3–5
However, many patients undergo biliary stenting prior to being
referred to the pancreatic surgeon. Furthermore, bacteriobilia can
occur without biliary stenting, particularly after instrumentation
of the bile duct.
Culturing the bile at the time of surgery can diagnose
bacteriobilia, determine which organisms are present, and identify
antibiotic sensitivities. In the present study, it was hypothesized
that treatment of positive intraoperative bile cultureswould reduce
infectious complications following pancreaticoduodenectomy.
Materials and methods
This study was approved by the institutional review board (IRB)
of Baylor College of Medicine and its affiliated hospitals. Subse-
quently, a retrospective cohort study was performed with 197
consecutive patients who underwent pancreaticoduodenectomy
carried out by a single surgeon between the years 2005 and 2011
(Fig. 1). The control group (n = 128) comprised patients who
underwent pancreaticoduodenectomy during 2005–2009. All of
these patients received a single prophylactic dose of preoperative
antibiotic (carbapenem 1 g) and one postoperative dose on the
first postoperative morning. Patients who were penicillin-allergic
were given ciprofloxacin 500 mg and metronidazole 500 mg. No
intraoperative bile cultures were obtained as this practice was not
performed routinely during pancreatic resections between 2005
and 2009. Beginning in 2009, intraoperative bile cultures were
obtained and infections were treated with culture-directed anti-
biotics. The treatment group (n = 69) therefore consisted of
patients who underwent pancreaticoduodenectomy from 2009 to
2011. This group received prophylactic doses of preoperative
antibiotics and were continued on antibiotic therapy until
intraoperative bile culture results were available. Patients with
bacteriobilia received postoperative antibiotics for a total of 10
days. A 10-day regimen was pursued because culture data results
are not normally available for 3 days. Therefore, treatment was
empiric initially, but tailored when culture data became available.
If treatment was modified, patients received appropriate antibi-
otic therapy for at least 7 days. In patients with negative bile
cultures, antibiotics were promptly discontinued. Intravenous
antibiotics were used in the immediate postoperative period and
oral antibiotics were continued at the time of discharge. Patients
with fungi cultured from the bile were treated with fluconazole
for 10 days.
Outcomes were recorded in a prospectively maintained data-
base and data compared with Fisher’s exact test for categorical
variables, the Wilcoxon rank sum test for ordinal variables, and a
two-sample t-test for continuous variables. A trained data analyst
entered data into an IRB-approved prospective database under the
supervision of the surgeon. All data were confirmed by source
documents and the accuracy of data entered into the electronic
database was periodically reviewed.
Demographic information including patient age and gender
were obtained from the medical record. A stated medical history
of, or presence in the medical record of a history of diabetes
mellitus, chronic obstructive pulmonary disease, obesity,
smoking, preoperative neoadjuvant chemotherapy or radiation,
and preoperative laboratory values including haematocrit, serum
creatinine and albumin were recorded. Obesity was defined as a
body mass index (BMI) of ≥30 kg/m2. Tobacco status was rec-
orded according to whether the patient had never been, ever been
or was currently a smoker. Preoperative anaemia was defined by a
haematocrit value of <36%. Renal insufficiency was defined as
preoperative serum creatinine of ≥1.2 mg/dl. Hypoalbuminaemia
was defined as serum albumin of <3.2 mg/dl. The American
Society of Anesthesiologists (ASA) class was obtained from the
anaesthesia record. The presence of preoperative biliary stenting
was also recorded.
Intraoperative characteristics recorded from the anaesthesia
record included administration of preoperative antibiotic within
1 h of incision, intraoperative blood transfusions and operative
time, defined as the time from incision to the application of the
final wound dressing. Intraoperative hypothermia was defined as
a single temperature recording of <36.5 °C. Intraoperative hyper-
glycaemia was defined as a single blood glucose reading of
≥200 mg/dl. Intraoperative estimated blood loss (EBL) was also
obtained from the anaesthesia record, not from the surgeon’s
operative report. The presence or absence of vein resection and
drain insertion were obtained from the surgeon’s operative
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Figure 1 Study design
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report. All specimens were submitted for pathologic analysis, and
the diagnosis and staging were recorded.
All complications occurring within 90 days of the date of
surgery were recorded using specific and standardized definitions.
Complications were defined and graded in severity using the
Common Terminology Criteria for Adverse Events (CTCAE)
Version 4.06 (Grades 1–5) unless otherwise stated. Pancreatic
fistula was defined and graded using the three-tiered definition
proposed by the International Study Group on Pancreatic Fistula
(ISGPF).7 Delayed gastric emptying was defined and graded using
the schema proposed by the International Study Group of Pan-
creatic Surgery (ISGPS).8 To calculate the median complication
severity composite score (sum of all complication grades for
each patient), grades A, B, and C were converted to scores of 1, 2
and 3, respectively, for these complications. The median and
interquartile range for the treatment group, control group and
entire study population were determined and reported. Hospital
length of stay (LoS) was calculated from the day of surgery
through to and including the day of discharge during the index
admission.
Wound infections were defined as drainage from the operative
site with a positive culture or Gram stain. However, if the patient
required an intervention such as a bedside incision and drainage
procedure, or was documented at another institution to have
obvious signs of infection, such as purulent drainage, even if
culture data were not obtained, the event was recorded as a wound
infection. Pancreaticoduodenectomy patients were followed up by
the operating surgeon for 60 days.
Results
Higher incidences of elevated creatinine (19% versus 4%; P =
0.004) and preoperative hyperglycaemia (18% versus 7%; P =
0.053) were observed in the control group, but there was no sig-
nificant difference in the prevalence of diabetes between the two
groups (22% versus 13%; P = 0.156). Fewer patients in the control
group underwent preoperative biliary stenting (48% versus 67%;
P = 0.017) and intra-peritoneal drains were placed at the time of
resection more frequently in the control group (85% versus 38%;
P < 0.0001). The treatment and control groups were otherwise
similar (Tables 1 and 2).
Of the 69 patients in the treatment group from whom
intraoperative bile cultures were obtained, 41 (59%) were found
to have bacteriobilia (Table 3). Aerobic bacteria were cultured in
32 (78%) patients, anaerobic bacteria in two (5%), mixed aerobic
and anaerobic bacteria in six (15%), and fungal organisms in 18
(44%) patients. In the group of patients with bacteriobilia, 34
(83%) had undergone preoperative biliary stenting; among those
with biliary candidiasis, six (37%) had undergone preoperative
biliary stenting (Table 4).
Treatment of positive intraoperative bile cultures with a 10-day
course of antibiotics was associated with a decrease in the rate of
postoperative wound infections, experienced by 16 (12%) patients
in the control group and two (3%) in the treatment group (P =
0.036). Overall complication severity also decreased from a score
of 1 in the control group to 0 in the treatment group (P = 0.017)
(Table 5). There was no significant difference in the rate of other
Table 1 Demographics and clinical characteristics of the study population
All patients
(n = 197)
n (%)
Treated group
(n = 69)
n (%)
Control group
(n = 128)
n (%)
P-value
Male 90 (46) 40 (58) 50 (39) 0.016
Age ≥65 years 93 (47) 69 (38) 57 (46) 0.370
Obesity (body mass index of ≥30 kg/m2) 51 (26) 20 (29) 31 (24) 0.499
Diabetes mellitus 32 (16) 15 (22) 17 (13) 0.156
Preoperative hyperglycaemia (≥200 mg/dl) 28 (14) 5 (7) 23 (18) 0.053
Chronic obstructive pulmonary disease 8 (4) 1 (1) 7 (6) 0.265
Smoking history 117 (59) 38 (55) 79 (62) 0.392
Never 80 (40) 31 (45) 49 (38)
Ever 72 (37) 26 (38) 46 (36)
Current 45 (23) 12 (17) 33 (26)
Preoperative serum albumin <3.2 mg/kl 17 (8) 9 (13) 8 (6) 0.117
Preoperative anaemia (haematocrit <36) 85 (43) 25 (36) 60 (47) 0.226
Preoperative serum creatinine ≥1.2 mg/dL 27 (14) 3 (4) 24 (19) 0.004
Preoperative neoadjuvant therapy 3 (2) 3 (4) 0 0.077
ASA class ≥3 134 (68) 49 (71) 85 (66) 0.527
Preoperative biliary stent placement 108 (55) 46 (67) 62 (48) 0.017
ASA, American Society of Anesthesiologists.
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infectious complications. Hospital LoS was similar in both groups
(9.6 days in the control group versus 9.7 days in the treatment
group).
Discussion
Prior studies have shown that preoperative biliary stenting
and bacteriobilia are associated with an increased risk for wound
and intra-abdominal infectious complications following
pancreaticoduodenectomy.2–5 In this retrospective cohort study of
197 consecutive patients undergoing pancreaticoduodenectomy,
culture-directed treatment of bacteriobilia reduced the incidence
of wound infections from 12% to 3%. The overall score for com-
plication severity also decreased between the two groups. There
was no statistically significant reduction in the incidence of other
specific infectious complications.
Table 2 Intraoperative characteristics of the study population
All patients
(n = 197)
Treated group
(n = 69)
Control group
(n = 128)
P-value
Preoperative antibiotic within 1 h of incision, n (%) 197 (100%) 69 (100%) 128 (100%)
Intraoperative blood transfusion, n (%) 37 (19%) 11 (16%) 26 (20%) 0.567
Intraoperative hypothermia (<36.5 °C), n (%) 193 (98%) 68 (99%) 125 (97%) 1.000
Intraoperative hyperglycaemia (≥200 mg/dl), n (%) 9 (5%) 5 (7%) 4 (3%) 0.477
Length of operation, min, mean ± SEM 458 ± 8 459 ± 12 457 ± 11 0.896
Blood loss, ml, mean ± SEM 541 ± 44 471 ± 53 579 ± 62 0.186
Vein resection, n (%) 26 (13%) 12 (17%) 14 (11%) 0.270
Drain used, n (%) 135 (69%) 26 (38%) 109 (85%) <0.001
Pathology, n (%) 0.003
Adenocarcinoma 104 (53%) 47 (68%) 57 (45%)
Pancreatitis 28 (14%) 3 (4%) 25 (20%)
IPMN 24 (12%) 5 (7%) 19 (15%)
Neuroendocrine tumour 10 (5%) 4 (6%) 6 (5%)
Other 22 (11%) 8 (12%) 14 (11%)
SEM, standard error of the mean; IPMN, intraductal papillary mucinous neoplasm.
Table 3 Microbiology of positive bile, wound, and intra-abdominal abscess cultures
Bile
(n = 41)
n (%)
Wound infections
(n = 15)a
n (%)
Intra-abdominal
abscess
(n = 13)
n (%)
Anaerobic 2 (5) 4 (27) 4 (27)
Aerobic 32 (78) 7 (47) 7 (47)
Mixed (anaerobic and aerobic bacteria) 6 (15) 3 (20) 4 (27)
Indeterminate culture 0 1 (7) 0
Fungal 18 (44) 1 (7) 2 (13)
Mono-organism 7 (17) 11 (73) 9 (60)
Polyorganism 34 (83) 4 (27) 4 (27)
Enterococcus spp. 25 (61) 7 (47) 6 (40)
Escherichia coli 11 (27) 2 (13) 2 (13)
Klebsiella spp. 16 (39) 0 3 (20)
Enterobacter spp. 9 (22) 2 (13) 2 (13)
Vancomycin-resistant Enterococcus spp. 6 (15) 0 2 (13)
Streptococcus viridians 16 (39) 0 0
Other 32 (78) 6 (40) 7 (47)
Candida albicans 13 (72) 1 (7) 1 (7)
Candida perfingens 3 (17) 0 0
Candida glabrata 2 (11) 0 1 (7)
aFor three wound infections, culture data were not obtained.
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Recent initiatives such as the National Surgical Quality
Improvement Program (NSQIP) and the Surgical Care Improve-
ment Project (SCIP) have focused on controlling factors associ-
ated with perioperative infections in an effort to reduce
additional health care costs. Furthermore, medical care has now
entered an era in which reimbursement is denied when certain
‘preventable’ complications, such as postoperative infections,
occur. An analysis of the economic impact of postoperative infec-
tions by Duke University reported that these infections are
responsible for additional annual hospital charges of US$1.6 bn
in the USA alone.9 Patients with methicillin-resistant Staphylo-
coccus aureus (MRSA) surgical site infections have extended hos-
pital stays (median additional days: 5) and incur a 1.19-fold
increase in hospital charges per patient.9 At the present study
institution, the cost of culture-directed treatment of positive bile
cultures was estimated to be around US$400 per patient and
although the exact cost to the hospital system of each postopera-
tive infection cannot be calculated, it is estimated to be signifi-
cantly higher than the cost of treating bacteriobilia, especially if
patients with infections require hospital admissions, diagnostic
radiology services, interventional radiology procedures, repeated
laboratory tests or i.v. antibiotic therapy. Given the incidence of
wound infection following pancreaticoduodenectomy, the study
of strategies that might potentially reduce this complication is
clearly important.
A number of factors have been reported to influence the inci-
dence of postoperative infectious complications. These include
smoking, skin preparation, prophylactic antibiotic administra-
tion, intraoperative temperature regulation, and blood glucose
control.10 These factors were assessed in the current study, but no
differences between the two cohorts were identified. However, not
all potential confounding factors could be controlled in this retro-
spective cohort study. The use of preoperative biliary stenting was
more frequent in the treatment group. Increased use of biliary
stenting would normally be associated with an increase in infec-
tious complications in the treatment group, but, interestingly,
there was a decrease in the rate of infectious complications in
this group.
Prior studies have focused on the use of preoperative biliary
stenting, including the type of stent used, the length of time from
stenting to operation, and its effect on infectious complications.11
In clinical practice, a majority of patients undergo biliary stenting
prior to referral and preoperative biliary stenting is necessary to
allow a patient to travel to a high-volume pancreatic treatment
centre at which superior surgical outcomes have been docu-
mented.12 In the current study, preoperative biliary stenting con-
firmed the known association with bacteriobilia.13 However,
bacteriobilia also occurs without stenting and is probably second-
ary to the spread of bacteria or fungus from the stomach or
intestine. Bacteriobilia seen in the absence of stenting may also
occur secondary to biliary instrumentation or bacteraemia. In the
present study, 13% of patients without preoperative biliary
stenting had positive bile cultures. Therefore, even if preoperative
biliary stenting could be avoided, the problem of bacteriobilia at
the time of pancreaticoduodenectomy would persist in some
cases.
To the present authors’ knowledge, this is the first study to
evaluate the impact of treatment of intraoperatively obtained bile
cultures during pancreaticoduodenectomy on short-term postop-
erative outcomes. In this study, there was a non-significant
increase in abdominal abscess formation in the treatment group.
Interestingly, all but three of the patients who developed an
abdominal abscess also had a pancreatic fistula. Prior studies have
shown that pancreatic fistula is a significant risk factor for
abdominal abscess and these abscesses are often polymicrobial
and include non-enteric organisms.13 Treatment of bacteriobilia
may be insufficient to prevent abdominal abscess in the setting of
a postoperative pancreatic fistula.
The present study is also the first to evaluate the incidence of
fungal organisms detected by intraoperative bile culture in
patients undergoing pancreaticoduodenectomy. The term ‘biliary
candidiasis’ is used to describe the presence of yeast in otherwise
sterile bile. Reports of biliary candidiasis over the last few years
have increased interest in its prevalence and clinical significance.14
Patients with cancer who have undergone neoadjuvant
chemoradiation may be immunosuppressed and at risk for biliary
candidiasis.
Among the observed infectious complications, fungi were cul-
tured from one wound infection and two intra-abdominal
abscesses. The significance of biliary candidiasis and the value of
its treatment are more controversial than the concept of treating
bacteriobilia. However, a recent study by Lenz et al. found that
Candida is commonly detected in bile, often in association with
immunosuppression.14 This group states that positive bile fungal
cultures do not simply signify colonization, but are to be consid-
ered true infections, and recommend screening for and treating of
biliary candidiasis. In this study, patients were not given preop-
erative anti-fungal therapy. Although the incidence of infections
secondary to Candida in this study was relatively low, the effect of
treating biliary candidiasis on postoperative complication rates
warrants further study.
Inappropriate use of antibiotics has been associated with an
increased incidence of colitis and the development of antibiotic
resistance.15 The current study did not detect any apparent
increase in the incidence of antibiotic-associated colitis when
bacteriobilia was treated for 10 days.
Table 4 Bile culture positivity among patients with and without
preoperative stenting
Positive
bacterial
culture
n (%)
Positive
fungal
culture
n (%)
Preoperative stent 34 (83) 6 (37)
No preoperative stent 5 (13) 1 (2)
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The present study was retrospective and subject to associated
biases. For example, the administration of empiric antibiotic
therapy against bacteriobilia was not randomized and, beginning
in 2009, all patients were treated empirically while awaiting
intraoperatively obtained bile culture results. The treatment
group was therefore compared with a historic control group oper-
ated in previous years at the study institution. Over the study
period, practice patterns also evolved and the use of intra-
abdominal drains following pancreaticoduodenectomy decreased
significantly throughout the study period and may confound the
interpretation of the impact of treatment of bacteriobilia on the
incidence of postoperative infections. However, the two groups
comprised a balanced distribution of clinical and operative vari-
ables. The authors are also confident that all infections, whether
diagnosed during the index admission or in the outpatient clinic
setting or at a remote institution closer to the patient’s home, were
appropriately documented in the database. The sample sizes for
the subgroup of patients with bacterial growth from wound infec-
tions or abdominal abscesses are small, and a larger study should
be conducted to further investigate any potentially causal relation-
ship. It is also unclear whether the provision of empiric, rather
than directed, antibiotic therapy would yield different results.
Further studies might focus on alternative durations of antibiotic
therapy to determine the optimal treatment course. This retro-
spective cohort study demonstrates that culture-directed treat-
ment of intraoperative bacteriobilia was associated with a
decreased incidence of postoperative wound infections among
patients undergoing pancreaticoduodenectomy. This retrospec-
tive study establishes a foundation upon which future randomized
prospective studies further investigating the relationship of
bacteriobilia with short-term postoperative infectious complica-
tions will be conducted.
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